Mesenchymal Stromal Cells for the Treatment of SARS-CoV-2 Induced Acute Respiratory Failure (COVID-19 Disease)  Mesenchymal Stromal Cells  30  Dose:1 × 108 MSCs through IV  Early Phase 1  USA  78